Skip to main content

Identification of the High Risk Angioplasty Patient

  • Chapter
  • 57 Accesses

Part of the book series: Interventional Cardiology ((INCA,volume 1))

Abstract

A recognition and understanding of the factors that make a patient truly at high risk for unsupported coronary angioplasty (PTCA) are necessary for the proper implementation of supported PTCA or an avoidance of the technique of PTCA altogether.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holmes DR Jr., Holubkov R, Vlietstra RE, et al. Co-investigators of the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.J Am Call Cordial1988; 12:1149–1155.

    Article  Google Scholar 

  2. de Feyter PJ, Serruys PW, Wijns W, van den Brand M. Emergency PTCA in unstable angina pectoris refractory to optimal medical treatment.N Engl J Med1985; 313:342–346.

    Article  PubMed  Google Scholar 

  3. de Feyter PJ, Serruys PW, Soward A, van den Brand M, Bos E, Hugenholtz PG. Coronary angioplasty for early postinfarction unstable angina.Circulation1985; 74:1365–1370.

    Article  Google Scholar 

  4. de Feyter PJ, Suryapranata H, Serruys PW, et al. Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome. J AmColl Cardiol1988; 12:324–333.

    Article  PubMed  Google Scholar 

  5. Gottlieb SO, Walford GD, Ouyang P, et a]. Initial and late results of coronary angioplasty for early postinfarction unstable angina.Cathet Cordial/as(ping1987; 13:93–99.

    Article  CAS  Google Scholar 

  6. Saban RD, Snyder LD, Synder BA, McKay RG, Lorell BH, Aroesty JM, Pasternak RC, Bradley AB, Monrad ES, Bains DS. Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarction.Am J Cordial1987; 59263–266.

    Article  CAS  Google Scholar 

  7. Black Al, Brown CS, Feres F, Roubin GS, Douglas JS. Coronary angioplasty and the spectrum of unstable angina pectoris: What determines risk? (abstr).Circulation1988; 78(Suppl. II):11–8.

    Google Scholar 

  8. Kamp O, Beatt KJ, de Feyter PJ, et al. Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.Am Heart J1989; 117:991–996.

    Article  PubMed  CAS  Google Scholar 

  9. Goldbaum T, Diciascio G, Cowley MJ, Vetrovec GW. Early occlusion following successful coronary angioplasty: Clinical and angiographie observations.Cathete Cardiovasc Diag1989; 17:22–27.

    Article  CAS  Google Scholar 

  10. Simpfendorfer C, Raymond R, Schraider J, et al. Early and long-term results of percutaneous transluminal coronary angioplasty in patients 70 years of age and older with angina pectoris.Am J Cardin!1988; 61:457--458.

    Article  Google Scholar 

  11. Kern MJ, Deligonul U, Galan K, et al. Percutaneous transluminal coronary angioplasty in octogenarians.Am J Cardiol1988; 61:457–458.

    Article  PubMed  CAS  Google Scholar 

  12. Good TH, Calkins M, Ligon R, McCallister BD, Hartzler GO. PTCA in the ultra-elderly (abstr).Circulation1987; 76(Suppl. IV):IV-464.

    Google Scholar 

  13. Kelsey SF, Miller DP, Leatherman LL, Cowley MJ, NHLBI PTCA Registry Investigators. Coronary angioplasty in the elderly: 1985–1986 NHLBI PTCA Registry.Circulation1988; 78(Suppl. B):11–283.

    Google Scholar 

  14. Lewin RF, Dorros G, Mathiak ML. Long term followup after successful coronary angioplasty in patients of age ?70 years (abstr).J Am Coll Cardiol1988; 11:51.

    Google Scholar 

  15. Coca F, Fajadet J, Caster L, Marco J. Transluminal coronary angioplasty in the elderly (over 70 years old): Immediate and long term results (abstr).Eur Heart J1987; 8(Suppl. 11):220.

    Google Scholar 

  16. Imburgia M, King TR, Soffer AD, Rich MW, Krone RJ, Salimi A. Early results and longterm outcome of percutaneous transluminal coronary angioplasty in patients age 75 years or older.Am J Cardiol1989; 1127–1129.

    Google Scholar 

  17. Ellis SG, Roubin GS, King SB, et al. Angiographie and clinical predictors of acute closure after native vessel coronary angioplasty.Circulation1988; 77:372–379.

    Article  PubMed  CAS  Google Scholar 

  18. McEniery PT, Hollman J, Knezinek V, et al. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women.Cathet Cardiovasc Diag1987; 13:364–371.

    Article  CAS  Google Scholar 

  19. Kelsey SF, Cowley MJ, Costigan T, Detre KM, Passamani E, Robertson T. Results of PTCA in women in 1985 (abstr).JAmColl Curdle!1987; 9:56.

    Google Scholar 

  20. Lorell BH, McCabe CH, Sipperly ME, Bairn DS. Women and PICA: No feminine mystique.Circulation1987; 76(Suppl. IV):IV-400.

    Google Scholar 

  21. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials.N Eng! J Med1987; 317:426–432.

    Article  CAS  Google Scholar 

  22. Ellis S, Cowley M, Vandormael M, Bulle T, DiSciascio G, and the MAPS Group. Risk of angioplasty in multivessel disease - improved assessment with modified ACCIAHA score. Circulation, submitted, 1990.

    Google Scholar 

  23. Conti CR, Brawley RK, Griffith LSC, et al. Unstable angina pectoris: Morbidity and mortality in 57 consecutive patients evaluated angiographically.Am J Cardio!1973; 32:745–750.

    Article  CAS  Google Scholar 

  24. Cairns JA, Fantus JG, Klassen GA. Unstable angina pectoris.Ant HeartJ1976; 92:373–386.

    Article  CAS  Google Scholar 

  25. Scanlon PJ. The intermediate coronary syndrome.Prag Cardiovasc Dis1981; 23:351–364.

    Article  CAS  Google Scholar 

  26. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina.N Eng! J Med1988; 319:1105–1111.

    Article  CAS  Google Scholar 

  27. Sherman CD, Litvack F, Grundfest W, et al. Coronary angioscopy in patients with unstable angina pectoris.N Eng! J Med1986; 315:913–919.

    Article  CAS  Google Scholar 

  28. Douglas JS, Lutz JF, Clements SD, et al. Therapy of large intracoronary thrombi in candidates for percutaneous translurninal coronary angioplasty (abstr).J Am Coll Cardiol1988; 11:238.

    Article  Google Scholar 

  29. Vetrovec GW, Leinbach RC, Gold HR, et al. Intracoronary thrombolysis in syndromes of ischemia: Angiographie and clinical results.Am Heart J1984; 104:946–952.

    Article  Google Scholar 

  30. Gotoh K, Minamino T, Katoh O, et al. The role of intracoronary thrombus in unstable angina: Angiographic assessment and thrombolytic therapy during ongoing attacks.Circulation1988; 77:526–534.

    Article  PubMed  CAS  Google Scholar 

  31. Gold HK, Johns JA, Leinbach RC, et al. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.Circulation1987; 75:1192–1199.

    Article  PubMed  CAS  Google Scholar 

  32. Topol EJ, Nicklas JM, Kander N, et al. Need for definitive coronary revascularization despite intravenous tissue plasminogen activator (t-PA) for unstable angina: Results of a randomized, double-blind, placebo-controlled trial.Circulation1987; 76(Suppl. IV):IV-452

    Google Scholar 

  33. Bates ER, McGillem MJ, Mickelson JK, Pitt B, Mancini G131. A monoclonal antibody to the platelet receptor GPI-lb/11A (7E3) preventsacutethrombosis in a canine model of coronary angioplasty.Circulation1988; 78:11–289.

    Google Scholar 

  34. Coller BS, Folts JD, Scudder LE, Smith SR. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein Ilb/lila receptor in an experimental animal model.Blood1986; 68:783–786.

    PubMed  CAS  Google Scholar 

  35. Cowley MJ, Corros G, Kelsey SF, Van Raden M, Detre KM. Acute coronary events associated with percutaneous transluminal coronary angioplasty.AtnJ Cardio! 1983;53:12C–16C.

    Google Scholar 

  36. Ryan TJ, Faxon DP, Gunnar RM, et al. Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). JAm Coll Cardio!1988; 12:529–545.

    Article  Google Scholar 

  37. Yock PG, Linker DT. Catheter-based two-dimensional ultrasound imaging. In Topol EJ, edTextbook of Interventional Cardiology.W.S. Saunders, Philadelphia, 1990, p. 816.

    Google Scholar 

  38. Topol EJ, Ellis SG, Fishman J, et al. Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.J Am Coll Cardiol1987; 9:1214–1218.

    Article  PubMed  CAS  Google Scholar 

  39. Cote G, Myler RK, Stertzer SH, et al. Percutaneous transluminal angioplasty of stcnotic coronary artery bypass grafts: 5 years’ experience. J AmColl Cardio!1987; 9:8–17.

    Article  CAS  Google Scholar 

  40. Douglas JS Jr., Gruentzig AR, King SB, et al. Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery. JAm Coll Cardiol1983; 2:745–754.

    Article  PubMed  Google Scholar 

  41. Saber RS, Edwards WD, Holmes DR Jr., Vlietstra RE, Reeder GS. Balloon angioplasty of aortocoronary saphenous vein bypass grafts: A histopathologic study of six grafts from five patients, with emphasis on restenosis and embolic complications.JAmColl Cardiol1988; 12:1501–1509.

    Article  CAS  Google Scholar 

  42. Corbelli J, Franco I, Hollman J, Simpfendorfer C, Galan K. Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery.Am J Cardio!1985; 56:398–403.

    Article  CAS  Google Scholar 

  43. Kussmaul JG. Percutaneous angioplasty of coronary bypass grafts: An emerging consensus.Cathet Cardiorasc Diag1988; 15:1–4.

    Article  Google Scholar 

  44. Liu MW, Douglas JS, King SB, Gruentzig A. Angiographie predictors of coronary embolization in the PTCA of vein graft lesions (abstr).Circulation1989; 80(Suppl. II):11–172.

    Google Scholar 

  45. Aueron F, Gruentzig A. Distal embolization of a coronary artery bypass graft atheroma during percutaneous transluminal coronary angioplasty.Ain J Cardiol1984; 53:953–954.

    Article  CAS  Google Scholar 

  46. Shintshak TM, Giorgi LV, Johnson WL, et al. Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft. J Ant Col!Cardio!1988; 12:1205–1214.

    Article  Google Scholar 

  47. Hill DM, McAuley BJ, Sheehan DJ, et al, Percutaneous transluminal angioplasty of internal mammary artery bypass grafts.J Am Coll Cardiol1989; 13:221A.

    Google Scholar 

  48. Bell MR, Vlietstra RE, Bresnahan DR, Holmes DR. Percutaneous transluminal angioplasty of left internal mammary artery grafts using a femoral approach. JAm Coll Cardiol1989; 13:221A.

    Google Scholar 

  49. Sketch MH, Perez JA, Quigley PJ, et al. Internal mammary artery graft angioplasty; Clinical and angiographie follow-up.J Am Coll Cardio!1989; 13,221A.

    Google Scholar 

  50. Andreae GE, Myler RK, Clark DA, Shaw RE, Murphy MC. Acute complications following angioplasty of totally occluded vessels.Circulation1987; 76(Suppl. IV):IV-400.

    Google Scholar 

  51. Klein LW, Agarwal JB, Helfant RH. The resolution of coronary collaterals after successful percutaneous transluminal coronary angioplasty.Am Heart1988; 115:554–558

    Article  CAS  Google Scholar 

  52. O’Keefe JH, Reeder GS, Miller GA, Bailey KR, Holmes DR. Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times.Am J Cardio!1989; 63:27–29.

    Article  Google Scholar 

  53. Schwartz L, Bourassa MG, Lesperance J, et al. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.N Eng! J Med1988; 318:1714–1719.

    Article  CAS  Google Scholar 

  54. White CW, Chaitman B, Lassar TA, et al., and the Ticlopidine Study Group (abstr).Circulation1987; 76(Suppl. IV):IV-400.

    Google Scholar 

  55. Chesebro JH, Webster MWI, Reeder GS, Mock MB, Grill DE, Bailey KR, Steichen S, Fuster V. Coronary angioplasty: Antiplatelet therapy reduces acute complications but not restenosis (abstr)Circulation1989; 80(Suppl. 1):II-64.

    Google Scholar 

  56. Mufson L, Black A, Roubin G, et al. A randomized trial of aspirin in PTCA: Effect of high vs. low dose aspirin on major complications and restenosis (abstr).JAmColt Cardiol1988; 11:236.

    Google Scholar 

  57. Lembo NJ, Black AJ, Roubin GS, et al. Does the addition of dipyridamole to aspirin decrease acute coronary angioplasty complications? The results of a prospective randomized clinical trial (abstr).J Am Coll Cardiol1988; 11:237.

    Article  Google Scholar 

  58. Emory University Coronary Angiography Data Bank, unpublished observations.

    Google Scholar 

  59. Patrono C, Ciabattoni G, Patrignani P, et al. Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation1985; 72:1177–1184.

    Article  PubMed  CAS  Google Scholar 

  60. Paton TW, Walker SE, Leung FYK, Little AH. Effect of cimetidinc on bioavailability of enteric coated aspirin tablets.Clin Pharm1983; 2:165–166.

    PubMed  CAS  Google Scholar 

  61. Swanson KT, Vlietstra RE, Holmes DR, et al. Efficacy of adjunctive dextran during per-cutaneous transluminal coronary angioplasty.Am J Cardiol 1984;54:447–448.

    Article  PubMed  CAS  Google Scholar 

  62. Bygdeman S, Eliasson R, Guibring B. Effect of dextran infusion on the adenosine phosphate-induced adhesiveness and the spreading capacity of human blood platelets.Thrornb Diatb Hacrnorrh1966; 15:451–456.

    CAS  Google Scholar 

  63. Weiss HJ. The effect of clinical dextran on platelet aggregation, adhesion, and the ADP release in man: In vivo and in vitro studies.J Lab Clin Med1967; 69:37–46.

    PubMed  CAS  Google Scholar 

  64. Data LL, Nies AS. Dextran 40.Ann Intern Med1974; 81:500–504.

    PubMed  CAS  Google Scholar 

  65. Heras M, Chesebro JH, Penny WJ, et al. Importance of adequate heparin dosage in arterial angioplasty in a porcine model.Circulation1988; 78:654–660.

    Article  PubMed  CAS  Google Scholar 

  66. Saba 141, Saba SR, Morelli GA. Effect of heparin on platelet aggregation.Anil Hematol1984; 17:295–306.

    Article  Google Scholar 

  67. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation.J Clin Invest1980; 65:64–73.

    Article  PubMed  CAS  Google Scholar 

  68. Saba HI, Saba SR, Blackburn CA, Hartman RC, Mason RG. Heparin neutralization of PGI2: Effects upon platelets.Science1979; 205:499–501.

    Article  PubMed  CAS  Google Scholar 

  69. Ellis SG, Roubin GS, WilentzjDouglas JS, King SB. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.Am Heart J 1989; 117:777–782.

    Article  PubMed  CAS  Google Scholar 

  70. Lukas MA, Deutsch E, Laskey WK. Beneficial effect of heparin therapy on PTCA outcome in unstable angina (abstr). JAm Coll Cardiol1988; (Suppl. II):132.

    Google Scholar 

  71. Gabliani G, Deligonul U, Kern MJ, Vandormael M. Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: Temporal relationship to discontinuation of anticoagulation.Am Heart J1988; 116:696–700.

    Article  PubMed  CAS  Google Scholar 

  72. Ogilby JD, Kopelman HA, Klein LW, Agarwal JB. Adequate heparinization during PTCA: Assessment using activated clotting time (abstr).J Am Coll Cardiol1988; 11:237.

    Article  Google Scholar 

  73. Hariuchi K, Mizuno K, Matsui H, et al. Improved ischemic tolerance during percutaneous transluminal coronary angioplasty (PTCA) by antianginal agents (abstr).Circulation1987; 76 (Suppl. I V):IV-275.

    Google Scholar 

  74. Darius H, Schmucker B. Antianginal agents administered intracoronarily ameliorate functional impairment and extend time to ischemia during PTCA.Circulation 1987; 76(Suppl. lV):IV-275.

    Google Scholar 

  75. Lam JYT, Chesebro JH, Fuster V. Platelets. Vasoconstriction and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.Circulation1988; 78:712–716.

    Article  PubMed  CAS  Google Scholar 

  76. Babbit DG, Perry JM, Forman MB. Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty.J Am Coll Cardiol1988; 12:1377–1381.

    Article  Google Scholar 

  77. Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty.Circulation1988; 78:1323–1334.

    Article  PubMed  CAS  Google Scholar 

  78. Holtman J, Gruentzig AR, Douglas JS Jr., King SB, ischinger T, Meier B. Acute occlusion after percutaneous transluminal coronary angioplasty - A new approach.Circulation1983; 68:725–732.

    Article  Google Scholar 

  79. Sinclair IN, McCabe GH, Sipperly ME, Bairn DS. Abrupt reclosure: Predictors, therapeutic options, and long-term outcome.J Am Coil Cardiol1988; 11:132A.

    Google Scholar 

  80. Palazzo AM, Gustafson GM, Santini E, Kemp HG. Unusually long inflation times during percutaneous transluminal coronary angioplasty.Cathet Cardiovasr Dian1958; 14:154–158.

    Article  Google Scholar 

  81. Smith JE, Quigley PJ, Tcheng JE, Bauman RP, Thomas J, Stack RS. Can prolonged perfusion balloon inflations salvage vessel patency after failed angioplasty? (abstr).Circulation1989; 80(Suppl. II):I1–373.

    Article  Google Scholar 

  82. Hinohara T, Simpson JB, Phillips HR, et al. Transluminal catheter reperfusion: A new technique to reestablish blood flow after coronary occlusion during percutaneous trans-lumina] coronary angioplasty.Aar J Cardiol1985; 57:684–686.

    Article  Google Scholar 

  83. Hinohara T, Simpson JB, Phillips HR, Stack RS. Transluminal intracoronary reperfusion catheter: A device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery.J Am Coll Cordial1988; 11:977–982.

    Article  CAS  Google Scholar 

  84. Douglas JS, King SB, Roubin GS, Murphy DA, Namay DL, Anderson HV. Efficacy of coronary artery perfusion catheters in patients with failed angioplasty and acute myocardial ischemia. JAm Coll Cardiol1987; 9:105A.

    Google Scholar 

  85. Sigwart U, Urban P, Golf S, et al. Emergency stenting for acute occlusion after coronary balloon angioplasty.Circulation 1988; 78:1121–1127.

    Article  PubMed  CAS  Google Scholar 

  86. Sinclair IN, Dear WE, Saftan RD, Plokker TM, Spears JR, the LBA Study Group. Acute closure post PICA successfully treated with laser balloon angioplasty (abstr).Circulation1989; 80(Suppl. II):II-476.

    Google Scholar 

  87. Kerciakes D. Personal communication.

    Google Scholar 

  88. Cohen BM, Buchbinder M, Kozina J, Podolia R, Peterson KL, Ross J Jr. Rethrombosis during angioplasty in myocardial infarction and unstable syndromes: Efficacy of intracoronary urokinase and redilation (abstr).Circulation1988; 78(Suppl. II):II-8.

    Google Scholar 

  89. Curling PE, Weintraub WS, Joncs EL, Talley D, Craver JM, Guyton RA. Failed elective coronary angioplasty mandating bypass surgery vs. elective coronary surgery: A case control study.Circulation 1988;78(Suppl. 1I):II-476.

    Google Scholar 

  90. Ellis SG, Roubin GS, King SB, et al. In-hospital cardiac mortality after acute closure after coronary angioplasty: Analysis of risk factors from 8207 procedures.J Am Coil Cardiol1988; 11:211–216.

    Article  CAS  Google Scholar 

  91. Park DD, Laramec LA, Tcirstcin P, et al. Major complications during PTCA: An analysis of 5413 cases (abstr). JAnt Coll Cardiol1988; 11:237.

    Article  Google Scholar 

  92. Harnarayan C, Bennett, MA, Pentecost BL, Brewer 11B. Quantitative study of infarcted myocardium in cardiogenic shock.Br Heart J1970; 32:728–732.

    Article  PubMed  CAS  Google Scholar 

  93. Kalbfleisch H, Hort W. Quantitative study on the size of coronary artery supplying areas postmortem.Ain Heart J1977; 94:183–188.

    Article  CAS  Google Scholar 

  94. James TN. Anatomy of the coronary arteries in health and disease.Circulation1965; 32:1020–4029.

    Article  PubMed  CAS  Google Scholar 

  95. Kennedy JW, Kaiser G, Fisher L. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).J Thorax Cardiovasr Surg1980; 80:876–882.

    CAS  Google Scholar 

  96. Kennedy JW, Kaiser G, Fisher L, et al. Clinical and angiographie predictors of operative mortality from the collaborative study in coronary artery surgery (CASS).Circulation1981; 63:793–799.

    Article  PubMed  CAS  Google Scholar 

  97. Kirklin JW, Blackston E, Rogers WJ. The plights of the invasive treatment of ischemic heart disease. JAm Coil Cardiol1985; 5:158–167.

    Article  CAS  Google Scholar 

  98. Vogel RA. Supported angioplasty. In Topol EJ, edTextbook i f Interventional Cardiology.W.B. Saunders, Philadelphia, 1990, pp. 467–476.

    Google Scholar 

  99. Smalling RW, Sweeney MJ, Cassidy DB, Barrett RL, Morris RE, Lammermeier DE, Key PG, Haynie MP, Frazier OH, Wampler R. Hemodynamics in cardiogenic shock after acute myocardial infarction with the hemopump assist device.Circulation1989; 80(Suppl. II): 11–624.

    Google Scholar 

  100. Jacobs AK, Faxon DP. Retroperfusion and PTCA. In Topol EJ, edTextbook of Interventional Cardiology.W.B. Saunders, Philadelphia, 1990, pp. 477–495.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Ellis, S.G. (1991). Identification of the High Risk Angioplasty Patient. In: Shawl, F.A. (eds) Supported Complex and High Risk Coronary Angioplasty. Interventional Cardiology, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3890-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3890-5_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6735-2

  • Online ISBN: 978-1-4615-3890-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics